- Report
- April 2025
- 450 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- November 2024
- 450 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- November 2024
- 250 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- November 2024
- 250 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- November 2024
- 500 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- November 2024
- 350 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- April 2025
- 1400 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 183 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 216 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2023
- 190 Pages
Global
From €5369EUR$5,899USD£4,603GBP
- Report
- August 2022
- 121 Pages
Global
From €1182EUR$1,299USD£1,014GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3185EUR$3,500USD£2,731GBP
- Report
- March 2023
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2023
- 145 Pages
Global
From €2867EUR$3,150USD£2,458GBP
- Book
- November 2007
- 694 Pages
- Book
- March 2020
- 160 Pages

Molecular Medicine is a branch of pharmaceuticals that focuses on the study of molecular mechanisms of disease and the development of treatments based on this knowledge. It is a rapidly growing field, with advances in biotechnology and genomics leading to the development of new treatments and diagnostics. Molecular Medicine is closely linked to personalized medicine, which uses genetic information to tailor treatments to individual patients. This approach has the potential to improve patient outcomes and reduce healthcare costs.
Molecular Medicine is a key component of the pharmaceutical industry, with many companies investing in research and development of new treatments. Examples of companies in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more